The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients

Objectives: A growing body of data illustrates the importance of microalbuminuria (MAU) as a strong predictor of cardiovascular risk in the hypertensive population. The present study was designed to define the prevalence of MAU and associated cardiovascular risk factors among Turkish hypertensive outpatients. Study design: Representing the Turkish arm of the multinational i-SEARCH study involving 1,750 sites in 26 countries around the world, a total of 1,926 hypertensive patients from different centers were included in this observational and cross-sectional survey study. Patients with reasons for a false-positive MAU test were excluded. The prevalence of MAU was assessed using a dipstick test, and patients were inquired about comorbidities, comedication, and known cardiovascular risk factors. Results: The overall prevalence of MAU was 64.7% and there was no difference between genders. Most of the patients (82.5%) had uncontrolled hypertension, 35.6% had dyslipidemia, and 35.5% had diabetes, predominantly type 2. Almost one-third of the patients (26.4%) had at least one cardiovascular-related comorbidity, with 20.3% having documented coronary artery disease (CAD). Almost all patients (96.8%) had one or more risk factors for cardiovascular disease in addition to hypertension, including family history of myocardial infarction or CAD, diabetes, dyslipidemia, lack of physical exercise, and smoking. A trend towards higher MAU values in the presence of CAD was determined. Conclusion: Microalbuminuria tests should be routinely used as a screening and monitoring tool for the assessment of subsequent cardiovascular morbidity and mortality among hypertensive patients. © 2011 Turkish Society of Cardiology.

Yazar Kozan Ö.
Özcan E.E.
Sancaktar O.
Kabakci G.
Sözcüer A.H.
Kerpeten A.
Delice A.
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/8197
Tek Biçim Adres 10.5543/tkda.2011.01477
Konu Başlıkları Albuminuria/complications/epidemiology
Cardiovascular diseases
Coronary artery disease
Hypertension/complications
Prevalence
Risk factors
Turkey/epidemiology
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
Scopus İndeksli Yayınlar Koleksiyonu
Dergi Adı Turk Kardiyoloji Dernegi Arsivi
Dergi Cilt Bilgisi 39
Dergi Sayısı 8
Sayfalar 635 - 645
Yayın Yılı 2011
Eser Adı
[dc.title]
The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients
Yazar
[dc.contributor.author]
Kozan Ö.
Yazar
[dc.contributor.author]
Özcan E.E.
Yazar
[dc.contributor.author]
Sancaktar O.
Yazar
[dc.contributor.author]
Kabakci G.
Yazar
[dc.contributor.author]
Sözcüer A.H.
Yazar
[dc.contributor.author]
Kerpeten A.
Yazar
[dc.contributor.author]
Delice A.
Yayın Yılı
[dc.date.issued]
2011
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Objectives: A growing body of data illustrates the importance of microalbuminuria (MAU) as a strong predictor of cardiovascular risk in the hypertensive population. The present study was designed to define the prevalence of MAU and associated cardiovascular risk factors among Turkish hypertensive outpatients. Study design: Representing the Turkish arm of the multinational i-SEARCH study involving 1,750 sites in 26 countries around the world, a total of 1,926 hypertensive patients from different centers were included in this observational and cross-sectional survey study. Patients with reasons for a false-positive MAU test were excluded. The prevalence of MAU was assessed using a dipstick test, and patients were inquired about comorbidities, comedication, and known cardiovascular risk factors. Results: The overall prevalence of MAU was 64.7% and there was no difference between genders. Most of the patients (82.5%) had uncontrolled hypertension, 35.6% had dyslipidemia, and 35.5% had diabetes, predominantly type 2. Almost one-third of the patients (26.4%) had at least one cardiovascular-related comorbidity, with 20.3% having documented coronary artery disease (CAD). Almost all patients (96.8%) had one or more risk factors for cardiovascular disease in addition to hypertension, including family history of myocardial infarction or CAD, diabetes, dyslipidemia, lack of physical exercise, and smoking. A trend towards higher MAU values in the presence of CAD was determined. Conclusion: Microalbuminuria tests should be routinely used as a screening and monitoring tool for the assessment of subsequent cardiovascular morbidity and mortality among hypertensive patients. © 2011 Turkish Society of Cardiology.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
Albuminuria/complications/epidemiology
Konu Başlıkları
[dc.subject]
Cardiovascular diseases
Konu Başlıkları
[dc.subject]
Coronary artery disease
Konu Başlıkları
[dc.subject]
Hypertension/complications
Konu Başlıkları
[dc.subject]
Prevalence
Konu Başlıkları
[dc.subject]
Risk factors
Konu Başlıkları
[dc.subject]
Turkey/epidemiology
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
ISSN
[dc.identifier.issn]
1016-5169
İlk Sayfa Sayısı
[dc.identifier.startpage]
635
Son Sayfa Sayısı
[dc.identifier.endpage]
645
Dergi Adı
[dc.relation.journal]
Turk Kardiyoloji Dernegi Arsivi
Dergi Sayısı
[dc.identifier.issue]
8
Dergi Cilt Bilgisi
[dc.identifier.volume]
39
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.5543/tkda.2011.01477
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/8197
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
28
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
13 Nisan 2024 17:45
Google Kontrol
Tıklayınız
patients cardiovascular hypertensive prevalence factors Turkish dyslipidemia disease hypertension diabetes Almost cardiovascular-related predominantly comorbidity artery one-third coronary documented having Objectives addition should Cardiology Society mortality morbidity subsequent assessment monitoring screening routinely including exercise family history
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms